Business Wire

NY-AQARA

17.5.2022 09:02:06 CEST | Business Wire | Press release

Share
Aqara Launches Amazon Brand Stores in Italy and Spain

Aqara, a leading provider of smart home products, announced the debut of its brand stores on Amazon.it and Amazon.es . Since the launch of Aqara’s first European brand store on Amazon UK in July 2021, the smart home manufacturer has expanded its Amazon presence to France, Germany, Italy and Spain, making the comprehensive portfolio of Aqara products easily accessible for smart home users across Europe.

Aqara has been selling in Italy and Spain on the Apple Online Store and via local retailers, and the brand has become increasingly popular among the local users for the build quality, the accessible prices and the wide compatibility with major ecosystems including HomeKit, Alexa, and Google Home. The launch of its Amazon brand stores will bring more Aqara products to the local markets, ranging from smart home hubs, smart sensors, security cameras, wired and wireless switches, to smart shade controllers.

The product lineup of the Aqara brand stores on Amazon.it and Amazon.es include:

Camera Hub G3 - Aqara’s flagship pan-and-tilt home security camera with AI-enabled facial and gesture recognition, built-in Zigbee hub function, as well as wide third-party ecosystem support (HomeKit, Alexa, Google Home);

Camera Hub G2H Pro - An indoor HomeKit Secure Video camera for home security, with the Zigbee hub function to enhance home security and smart home automations;

Hub M2 - The versatile and future-proof smart home hub that connects all Aqara devices and allows seamless integration across Aqara sensors and home automation devices;

Hub M1S - The wireless control center of Aqara accessories enabling home automation, local alarm, and remote control of smart devices, while it can also be used as a night light, siren, or doorbell;

Hub E1 - Aqara’s smallest smart home hub with a UBS-A port and adjustable shaft, allowing it to be flexibly placed and charged by USB devices such as PCs, power strips and outlets;

Door & Window Sensor - It detects when a window or a door is open in real time, and enables push notifications or/and local siren when the door/window opens unexpectedly;

Temperature & Humidity Sensor - It monitors temperature, humidity and atmospheric pressure in real time, and can connect with other Aqara devices for home automations and scenes;

Motion Sensor - It detects human movements with passive infrared and can work with other Aqara products to set home automations and scenes;

Motion Sensor P1 - An enhanced version of the iconic Motion Sensor, with a prolonged battery life of up to 5 years, and the configurable detection timeout as well as sensitivity levels;

Water Leak Sensor - It detects flood, and enables push notifications or/and local alarm activation to protect the property;

Vibration Sensor - It detects vibration, tilt and drop, alerts users when unexpected movement is detected, and can be used for home automations and scenes;

TVOC Air Quality Monitor - It detects the level of total volatile organic compounds (TVOC) in the air, as well as temperature and humidity, and can be used to enable push notifications, local siren, and home automations;

Smart Wall Switch H1 EU * - Aqara’s first wall switch designed for Europe, supporting both round European wall boxes and 86 mm square wall boxes and available in both With Neutral and No Neutral versions;

Smart Plug EU - It automates ordinary home appliances, and enables the remote control and timer switch of lights, fans, and other appliances.

Roller Shade Driver E1 - A retrofit roller shade controller to automate regular beaded-cord roller blinds, allowing users to set the shades by mobile control, voice command, preset schedule or via home automations;

Wireless Switch H1 - A remote switch with 7 configurable actions to control smart home devices or home scenes;

Wireless Mini Switch - A versatile and compact switch with 3 configurable actions to control smart home devices or home scenes;

Cube - A versatile controlling cube that recognizes 6 gestures (push, shake, rotate, tap twice, flip 90°, and flip 180°) for smart home control.

To celebrate the launch, Aqara now offers a limited-time offer of 5% extra discount for purchases on its Amazon.it store and Amazon.es store with the promo code AMAZONITES** . The offering is valid through May 19, 2022.

* Smart Wall Switch H1 EU is not available on Amazon.it.

** Promo code can be combined with coupons. Offer excludes the Hub M1S, the Camera Hub G3 and the Door & Window Sensor on Amazon.it, and excludes the Camera Hub G3 on Amazon.es.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release

Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5

HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release

HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a

Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 11:52:00 CEST | Press release

Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased.Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks.Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority. The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not mere

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye